Mondego Bio Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $23.4M

  • Investors
  • 3

Mondego Bio General Information

Description

Developer of targeted molecular therapeutics designed for immune-oncology treatment enhancement. The company is advancing selective inhibitors of PTPN2, a key regulator of the JAK-STAT pathway, with features including modulation of cytokine receptor signaling, improved IFN γ responsiveness, and optimized pharmacological profiles, enabling oncology researchers and clinicians to potentially increase the efficacy of cancer immunotherapy while maintaining favorable safety and tolerability outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Cantanhede Technology Park
  • Nucleus 4, Lot 8
  • Cantanhede, 3060-197
  • Portugal
+351 231
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Cantanhede Technology Park
  • Nucleus 4, Lot 8
  • Cantanhede, 3060-197
  • Portugal
+351 231

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mondego Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 18-Sep-2025 $23.4M Completed Startup
To view Mondego Bio’s complete valuation and funding history, request access »

Mondego Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Mondego Bio’s complete cap table history, request access »

Mondego Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biovance Capital Partners Venture Capital Minority
OrbiMed Growth/Expansion Minority
Torrey Pines Investment Venture Capital Minority
To view Mondego Bio’s complete investors history, request access »

Mondego Bio FAQs

  • When was Mondego Bio founded?

    Mondego Bio was founded in 2025.

  • Where is Mondego Bio headquartered?

    Mondego Bio is headquartered in Cantanhede, Portugal.

  • What industry is Mondego Bio in?

    Mondego Bio’s primary industry is Drug Discovery.

  • Is Mondego Bio a private or public company?

    Mondego Bio is a Private company.

  • What is Mondego Bio’s current revenue?

    The current revenue for Mondego Bio is .

  • How much funding has Mondego Bio raised over time?

    Mondego Bio has raised $23.4M.

  • Who are Mondego Bio’s investors?

    Biovance Capital Partners, OrbiMed, and Torrey Pines Investment have invested in Mondego Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process